423 related articles for article (PubMed ID: 28158504)
21. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
Nelson M; Amaya G; Clumeck N; Arns da Cunha C; Jayaweera D; Junod P; Li T; Tebas P; Stevens M; Buelens A; Vanveggel S; Boven K;
J Antimicrob Chemother; 2012 Aug; 67(8):2020-8. PubMed ID: 22532465
[TBL] [Abstract][Full Text] [Related]
23. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes.
Peebles K; Nchimba L; Chilengi R; Bolton Moore C; Mubiana-Mbewe M; Vinikoor MJ
J Trop Pediatr; 2015 Dec; 61(6):464-7. PubMed ID: 26338421
[TBL] [Abstract][Full Text] [Related]
24. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
[TBL] [Abstract][Full Text] [Related]
25. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
26. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
[TBL] [Abstract][Full Text] [Related]
28. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
[TBL] [Abstract][Full Text] [Related]
29. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
[TBL] [Abstract][Full Text] [Related]
30. Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV/HBV coinfection.
Nampala H; Luboobi LS; Mugisha JYT; Obua C; Jablonska-Sabuka M
Math Biosci; 2018 Aug; 302():67-79. PubMed ID: 29800563
[TBL] [Abstract][Full Text] [Related]
31. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
32. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Lukhwareni A; Gededzha MP; Amponsah-Dacosta E; Blackard JT; Burnett RJ; Selabe SG; Kyaw T; Mphahlele MJ
Viruses; 2020 Jun; 12(6):. PubMed ID: 32545313
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection.
Singh KP; Zerbato JM; Zhao W; Braat S; Deleage C; Tennakoon GS; Mason H; Dantanarayana A; Rhodes A; Rhodes JW; Torresi J; Harman AN; Revill PA; Crane M; Estes JD; Avihingsanon A; Lewin SR; Audsley J
PLoS Pathog; 2020 Sep; 16(9):e1008744. PubMed ID: 32898182
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
Ocama P; Seremba E; Apica B; Opio K
Afr Health Sci; 2015 Jun; 15(2):328-33. PubMed ID: 26124776
[TBL] [Abstract][Full Text] [Related]
36. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
[TBL] [Abstract][Full Text] [Related]
37. HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria.
Rivera AS; Machenry S; Okpokwu J; Olatunde B; Ugoagwu P; Auwal M; Sule H; Agaba P; Agbaji OO; Thio CL; Murphy RL; Hawkins C
Antivir Ther; 2021 Nov; 26(6-8):106-116. PubMed ID: 35485338
[TBL] [Abstract][Full Text] [Related]
38. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
Yang R; Gui X; Xiong Y; Gao SC; Yan Y
Int J Infect Dis; 2014 Nov; 28():29-34. PubMed ID: 25236390
[TBL] [Abstract][Full Text] [Related]
39. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
Kouanfack C; Aghokeng AF; Mondain AM; Bourgeois A; Kenfack A; Mpoudi-Ngolé E; Ducos J; Delaporte E; Laurent C
Antivir Ther; 2012; 17(2):321-6. PubMed ID: 22290198
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
Liégeois F; Boyer S; Eymard-Duvernay S; Carrieri P; Kouanfack C; Domyeum J; Maradan G; Ducos J; Mpoudi-Ngolé E; Spire B; Delaporte E; Kuaban C; Vidal L; Laurent C;
BMC Infect Dis; 2020 Jan; 20(1):49. PubMed ID: 31941464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
